Monday - December 15, 2025
TESARO, a GSK Subsidiary, Initiates Litigation Against AnaptysBio, Inc.
November 21, 2025
LONDON, England, Nov. 21 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release:

* * *

TESARO, a GSK subsidiary, initiates litigation against AnaptysBio, Inc.

GSK subsidiary, TESARO, Inc., confirms it has initiated litigation against AnaptysBio, Inc. in the Delaware Chancery Court. This action contends that recent conduct by AnaptysBio is in material breach of the existing license agreement with TESARO regarding th . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products